{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:28Z","timestamp":1786985488450,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031789","name":"Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","award":["PDF\/146\/84"],"award-info":[{"award-number":["PDF\/146\/84"]}],"id":[{"id":"10.13039\/100031789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.brainres.2025.149828","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:04:39Z","timestamp":1752566679000},"page":"149828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Deciphering Alzheimer\u2019s disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier"],"prefix":"10.1016","volume":"1863","author":[{"given":"Dar Junaid","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khursheed Ahmad","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masarat","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: Synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.brainres.2025.149828_b0010","doi-asserted-by":"crossref","unstructured":"Agnello, L., & Ciaccio, M. (2022). Neurodegenerative Diseases: From Molecular Basis to Therapy. In International Journal of Molecular Sciences (Vol. 23, Issue 21). MDPI. doi: 10.3390\/ijms232112854.","DOI":"10.3390\/ijms232112854"},{"issue":"4","key":"10.1016\/j.brainres.2025.149828_b0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.pbb.2008.09.010","article-title":"Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer\u2019s disease","volume":"91","author":"Ahmed","year":"2009","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: Classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.brainres.2025.149828_b0025","doi-asserted-by":"crossref","unstructured":"Akhtar, A., Gupta, S. M., Dwivedi, S., Kumar, D., Shaikh, M. F., & Negi, A. (2022). Preclinical Models for Alzheimer\u2019s Disease: Past, Present, and Future Approaches. In ACS Omega (Vol. 7, Issue 51, pp. 47504\u201347517). American Chemical Society. doi: 10.1021\/acsomega.2c05609.","DOI":"10.1021\/acsomega.2c05609"},{"key":"10.1016\/j.brainres.2025.149828_b0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0173(95)00016-X","article-title":"REVIEWS Acetylcholine\u00a0: a neurotransmitter for learning and memory\u00a0?","volume":"21","author":"Blokland","year":"1996","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.brainres.2025.149828_b0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer\u2019s disease: Inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2014.12.FOCUS14758","article-title":"Therapeutic strategies to improve drug delivery across the blood-brain barrier","volume":"38","author":"Azad","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.brainres.2025.149828_b0045","doi-asserted-by":"crossref","unstructured":"Barmaki, H., Nourazarian, A., & Khaki-Khatibi, F. (2023). Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease. In Frontiers in Aging Neuroscience (Vol. 15). Frontiers Media SA. doi: 10.3389\/fnagi.2023.1281338.","DOI":"10.3389\/fnagi.2023.1281338"},{"key":"10.1016\/j.brainres.2025.149828_b0050","first-page":"MDPI","article-title":"Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. In","volume":"Vol. 25, Issue 24","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.brainres.2025.149828_b0055","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000338626.93425.74","article-title":"Georges Marinesco and the early research in neuropathology","volume":"72","author":"Buda","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.brainres.2025.149828_b0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/17425247.2016.1178237","article-title":"Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases","volume":"13","author":"Cacciatore","year":"2016","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"4","key":"10.1016\/j.brainres.2025.149828_b0070","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.brainres.2025.149828_b0075","doi-asserted-by":"crossref","unstructured":"Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023). Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential. In Frontiers in Aging Neuroscience (Vol. 15). Frontiers Media SA. doi: 10.3389\/fnagi.2023.1258640.","DOI":"10.3389\/fnagi.2023.1258640"},{"issue":"2","key":"10.1016\/j.brainres.2025.149828_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.brainres.2025.149828_b0085","doi-asserted-by":"crossref","unstructured":"Chia, K., Klingseisen, A., Sieger, D., & Priller, J. (2022). Zebrafish as a model organism for neurodegenerative disease. In Frontiers in Molecular Neuroscience (Vol. 15). Frontiers Media S.A. doi: 10.3389\/fnmol.2022.940484.","DOI":"10.3389\/fnmol.2022.940484"},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase Inhibitors: Pharmacology and Toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"5134","key":"10.1016\/j.brainres.2025.149828_b0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative Stress, Glutamate, and Neurodegenerative Disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.brainres.2025.149828_b0100","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","article-title":"Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein","volume":"88","author":"Cras","year":"1991","journal-title":"PNAS"},{"issue":"19","key":"10.1016\/j.brainres.2025.149828_b0105","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.M312946200","article-title":"Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid \u03b2-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch\/Iowa Mutant Form of Amyloid \u03b2-Protein Precursor","volume":"279","author":"Davis","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.brainres.2025.149828_b0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/npp.2012.247","article-title":"Increased amyloid-\u03b2 peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice","volume":"38","author":"Desrumaux","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2025.149828_b0115","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.brainres.2025.149828_b0120","doi-asserted-by":"crossref","unstructured":"Ding, X., & Yao, P. (2013). Soy Protein\/Soy Polysaccharide Complex Nanogels: Folic Acid Loading, Protection, and Controlled Delivery.","DOI":"10.1021\/la401664y"},{"key":"10.1016\/j.brainres.2025.149828_b0125","doi-asserted-by":"crossref","unstructured":"Drummond, E., & Wisniewski, T. (2017). Alzheimer\u2019s disease: experimental models and reality. In Acta Neuropathologica (Vol. 133, Issue 2, pp. 155\u2013175). Springer Verlag. doi: 10.1007\/s00401-016-1662-x.","DOI":"10.1007\/s00401-016-1662-x"},{"key":"10.1016\/j.brainres.2025.149828_b0130","article-title":"Pathology of neurodegenerative diseases","volume":"Vol. 9, Issue 7","author":"Dugger","year":"2017"},{"issue":"8","key":"10.1016\/j.brainres.2025.149828_b0135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/j.1552-4604.1998.tb04812.x","article-title":"Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration","volume":"38","author":"Ebert","year":"1998","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1073\/pnas.91.1.380","article-title":"Topography of a binding site for small amnestic peptides deduced from structure-activity studies: Relation to amnestic effect of amyloid \u03b2 protein","volume":"91","author":"Flood","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6514","key":"10.1016\/j.brainres.2025.149828_b0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"In Nature (Vol."},{"issue":"4","key":"10.1016\/j.brainres.2025.149828_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040833","article-title":"Ultrasound-Mediated Blood\u2013Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies","volume":"14","author":"Gandhi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.brainres.2025.149828_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1357405","article-title":"Modeling sporadic Alzheimer\u2019s disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors","volume":"16","author":"Ganesan","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.brainres.2025.149828_b0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejphar.2007.04.011","article-title":"The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats","volume":"568","author":"Gojo","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"47","key":"10.1016\/j.brainres.2025.149828_b0165","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0170","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-023-08960-x","article-title":"Brain targeted luteolin-graphene oxide nanoparticle abrogates polyethylene terephthalate induced altered neurological response in zebrafish","volume":"51","author":"Guru","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.brainres.2025.149828_b0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jdiacomp.2008.02.011","article-title":"Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes","volume":"23","author":"Haidara","year":"2009","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.brainres.2025.149828_b0180","doi-asserted-by":"crossref","unstructured":"Hampel, H., Mesulam, M. M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., & Khachaturian, Z. S. (2018). The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. In Brain (Vol. 141, Issue 7, pp. 1917\u20131933). Oxford University Press. doi: 10.1093\/brain\/awy132.","DOI":"10.1093\/brain\/awy132"},{"issue":"6","key":"10.1016\/j.brainres.2025.149828_b0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1227\/00006123-198812000-00001","article-title":"Use of Implantable Pumps for Central Nervous System Drug Infusions to Treat Neurological Disease","volume":"23","author":"Harbaugh","year":"1988","journal-title":"Neurosurgery"},{"issue":"5054","key":"10.1016\/j.brainres.2025.149828_b0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s Disease: The Amyloid Alzheimer\u2019s disease","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"C","key":"10.1016\/j.brainres.2025.149828_b0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"5580","key":"10.1016\/j.brainres.2025.149828_b0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149828_b0205","article-title":"Therapeutic Potential of Thiophene-Based Chalcone Analog Against Acrylamide-Induced Neurotoxicity and Osteotoxicity","author":"Haridevamuthu","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149828_b0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0006-8993(97)01215-8","article-title":"Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer\u2019s disease","volume":"780","author":"Hauss-Wegrzyniak","year":"1998","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.brainres.2025.149828_b0215","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1021\/acsbiomaterials.8b01098","article-title":"Protein Nanoparticles: Promising Platforms for Drug Delivery Applications","volume":"4","author":"Jain","year":"2018","journal-title":"ACS Biomaterials Science and Engineering"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18388\/abp.2001_5127","article-title":"Dendrimers: properties and applications","volume":"48","author":"Klajnert","year":"2001","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.brainres.2025.149828_b0225","article-title":"Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress","volume":"2009","author":"Kumar","year":"2009","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"10.1016\/j.brainres.2025.149828_b0230","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1089\/jmf.2009.1251","article-title":"Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats","volume":"13","author":"Kumar","year":"2010","journal-title":"J. Med. Food"},{"key":"10.1016\/j.brainres.2025.149828_b0235","doi-asserted-by":"crossref","unstructured":"Kumar, A., Singh, A., & Ekavali. (2015). A review on Alzheimer\u2019s disease pathophysiology and its management: An update. In Pharmacological Reports (Vol. 67, Issue 2, pp. 195\u2013203). Elsevier B.V. doi: 10.1016\/j.pharep.2014.09.004.","DOI":"10.1016\/j.pharep.2014.09.004"},{"key":"10.1016\/j.brainres.2025.149828_b0240","first-page":"MDPI","article-title":"A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. In","volume":"Vol. 23, Issue 3","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149828_b0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-60761-898-0_17","article-title":"A\u03b2 Infusion and related models of Alzheimer dementia","volume":"48","author":"Lawlor","year":"2011","journal-title":"NeuroMethods"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0250","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative Tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2025.149828_b0255","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid b peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.brainres.2025.149828_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313168","article-title":"A review of the current mammalian models of alzheimer\u2019s disease and challenges that need to be overcome","volume":"22","author":"McKean","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.brainres.2025.149828_b0265","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7863\/jum.2009.28.7.871","article-title":"Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound","volume":"28","author":"Mei","year":"2009","journal-title":"J. Ultrasound Med."},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbr.2005.04.019","article-title":"Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum","volume":"163","author":"Mulder","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2025.149828_b0275","doi-asserted-by":"crossref","unstructured":"Murphy, M. P., & Levine, H. (2010). Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. In Journal of Alzheimer\u2019s Disease (Vol. 19, Issue 1, pp. 311\u2013323). IOS Press. doi: 10.3233\/JAD-2010-1221.","DOI":"10.3233\/JAD-2010-1221"},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0280","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/pharmaceutics7030344","article-title":"Enhancement of blood\u2013brain barrier permeability and delivery of antisense oligonucleotides or plasmid DNA to the brain by the combination of bubble liposomes and high-intensity focused ultrasound","volume":"7","author":"Negishi","year":"2015","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.brainres.2025.149828_b0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lfs.2014.05.017","article-title":"Animal models of dementia and cognitive dysfunction","volume":"109","author":"Neha","year":"2014","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.brainres.2025.149828_b0290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1227\/00006123-198610000-00011","article-title":"Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma","volume":"19","author":"Neuwelt","year":"1986","journal-title":"In Neurosurgery (Vol."},{"key":"10.1016\/j.brainres.2025.149828_b0295","doi-asserted-by":"crossref","unstructured":"Niazi, S. K. (2023). Non-Invasive Drug Delivery across the Blood\u2013Brain Barrier: A Prospective Analysis. In Pharmaceutics (Vol. 15, Issue 11). Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390\/pharmaceutics15112599.","DOI":"10.3390\/pharmaceutics15112599"},{"key":"10.1016\/j.brainres.2025.149828_b0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and alzheimer\u2019s disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2025.149828_b0305","first-page":"33","volume":"Vol. 38(3","author":"Ozkizilcik","year":"2017","journal-title":"Nanocarriers as CNS Drug Delivery Systems for Enhanced Neuroprotection"},{"key":"10.1016\/j.brainres.2025.149828_b0310","article-title":"The bioaccessibility of adsorped heavy metals on biofilm-coated microplastics and their implication for the progression of neurodegenerative diseases","volume":"Vol. 195, Issue 11","author":"Pan","year":"2023"},{"key":"10.1016\/j.brainres.2025.149828_b0315","first-page":"MDPI.","volume":"Vol. 14, Issue 6","author":"Pardo-Moreno","year":"2022","journal-title":"Therapeutic Approach to Alzheimer\u2019s Disease: Current Treatments and New Perspectives. In Pharmaceutics"},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","article-title":"Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model","volume":"163","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainres.2025.149828_b0325","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2015.12.033","article-title":"Colloids and Surfaces B\u00a0: Biointerfaces Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique","volume":"140","author":"Peres","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0330","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer\u2019s Disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine"},{"key":"10.1016\/j.brainres.2025.149828_b0335","doi-asserted-by":"crossref","unstructured":"Pinkiewicz, M., Pinkiewicz, M., Walecki, J., Zaczy\u0144ski, A., & Zawadzki, M. (2024). Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood\u2013Brain Barrier Disruption. In Cancers (Vol. 16, Issue 1). Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390\/cancers16010236.","DOI":"10.3390\/cancers16010236"},{"issue":"9","key":"10.1016\/j.brainres.2025.149828_b0340","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bbadis.2013.04.017","article-title":"Transgenic models of Alzheimer\u2019s disease: Better utilization of existing models through viral transgenesis","volume":"1832","author":"Platt","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(86)90177-4","article-title":"Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir","volume":"81","author":"Polsky","year":"1986","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.brainres.2025.149828_b0350","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","article-title":"Targeting Free Radicals in Oxidative Stress-Related Human Diseases","volume":"38","author":"Poprac","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2025.149828_b0355","doi-asserted-by":"crossref","unstructured":"Rajmohan, R., & Reddy, P. H. (2017). Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s disease Neurons. In Journal of Alzheimer\u2019s Disease (Vol. 57, Issue 4, pp. 975\u2013999). IOS Press. doi: 10.3233\/JAD-160612.","DOI":"10.3233\/JAD-160612"},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0360","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-021-03553-8","article-title":"Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy","volume":"16","author":"Rommasi","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.brainres.2025.149828_b0365","first-page":"MDPI","article-title":"Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders. In","volume":"Vol. 13, Issue 3","author":"Roussos","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.brainres.2025.149828_b0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.brainres.2025.149828_b0375","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"\u0160imi\u0107","year":"2016","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.brainres.2025.149828_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: A key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2025.149828_b0390","doi-asserted-by":"crossref","unstructured":"Singh, M., Guru, A., Murugan, R., Gopi, M., & Arockiaraj, J. (2023). Circular RNA ciRS-7 signature as a potential biomarker for the early detection of diabetes with Alzheimer\u2019s disease: a hypothesis. In Molecular Biology Reports (Vol. 50, Issue 10, pp. 8705\u20138714). Springer Science and Business Media B.V. doi: 10.1007\/s11033-023-08729-2.","DOI":"10.1007\/s11033-023-08729-2"},{"issue":"3\u20135","key":"10.1016\/j.brainres.2025.149828_b0395","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0278-5846(86)90030-8","article-title":"Pharmacologic modelling of Alzheimer\u2019s disease","volume":"10","author":"Sunderland","year":"1986","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"7628","key":"10.1016\/j.brainres.2025.149828_b0400","first-page":"7628","volume":"539","author":"Taylor","year":"2016","journal-title":"Neurodegenerative diseases 10."},{"issue":"44","key":"10.1016\/j.brainres.2025.149828_b0405","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.brainres.2025.149828_b0410","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00221-001-0917-4","article-title":"Electrolytic and ibotenic acid lesions of the nucleus basalis magnocellularis interrupt long-term retention, but not acquisition of two-way active avoidance,in rats","volume":"142","author":"Vale-Mart\u00ednez","year":"2002","journal-title":"Exp. Brain Res."},{"issue":"22","key":"10.1016\/j.brainres.2025.149828_b0415","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0420","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0306-4522(03)00545-1","article-title":"The toxicity of tumor necrosis factor-\u03b1 upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: Implications for Alzheimer\u2019s disease","volume":"121","author":"Wenk","year":"2003","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.149828_b0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2014.05.056","article-title":"Albumin nanoparticles for the delivery of gabapentin: Preparation, characterization and pharmacodynamic studies","volume":"473","author":"Wilson","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0430","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0029-1186084","article-title":"Cryptotanshinone, an acetylcholinesterase inhibitor from salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in morris water maze task","volume":"76","author":"Wong","year":"2010","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.brainres.2025.149828_b0435","doi-asserted-by":"crossref","first-page":"255","DOI":"10.37349\/en.2024.00048","article-title":"Current therapeutics for Alzheimer\u2019s disease and clinical trials","volume":"3","author":"Xiao","year":"2024","journal-title":"Exploration of Neuroscience"},{"key":"10.1016\/j.brainres.2025.149828_b0440","doi-asserted-by":"crossref","unstructured":"Yusuf, M., Khan, M., Khan, R. A., & Ahmed, B. (2013). evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer \u2019 s disease model. 21(September 2012), 300\u2013311. doi: 10.3109\/1061186X.2012.747529.","DOI":"10.3109\/1061186X.2012.747529"},{"key":"10.1016\/j.brainres.2025.149828_b0445","doi-asserted-by":"crossref","unstructured":"Zhao, Y. P., Ai, W. J., Zheng, J. F., Hu, X. L., & Zhang, L. S. (2024). A bibliometric and visual analysis of epigenetic research publications for Alzheimer\u2019s disease (2013\u20132023). In Frontiers in Aging Neuroscience (Vol. 16). Frontiers Media SA. doi: 10.3389\/fnagi.2024.1332845.","DOI":"10.3389\/fnagi.2024.1332845"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325003890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325003890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:12:41Z","timestamp":1779700361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325003890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":89,"alternative-id":["S0006899325003890"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149828","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering Alzheimer\u2019s disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149828"}}